A San Diego based bio tech company is developing a non opioid procedure to treat chronic pain.
Dr. Andrew Ghetti is the CEO at AnaBios Corporation , which is the first in the world to use human neurons for advancing pain drugs. He tells KOGO news models with rats and mice don't usually work.
He says drugs that seem to do wonders in animals are completely ineffective or outright toxic in humans
AnaBios' approach is to treat the nerve paths with a series of drugs targeting molecules in the body called sodium channels. These are responsible for the electric impulses in nerves and are good targets for pain treatment.
The plan is to zero in only on the nerve that is causing pain. There are no addictive properties, and he hopes to have it in practice in the next few years. You can read more at Anabios.com.
Photo Credit: AnaBios